Bayer Xarelto wins CDR recommendation for stroke prevention in AF patients
Linkedin

Bayer Xarelto wins CDR recommendation for stroke prevention in AF patients

London : United Kingdom | Apr 23, 2012 at 10:26 PM PDT
Source: Pharmaceutical Industry News
XX XX
Views: Pending
 
Xarelto (rivaroxaban tablet) is indicated for the prevention of stroke and systemic embolism in patients with AF, in whom anticoagulation is appropriate. FULL ARTICLE AT Pharmaceutical Industry News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.